<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04972695</url>
  </required_header>
  <id_info>
    <org_study_id>PI 21-2278</org_study_id>
    <nct_id>NCT04972695</nct_id>
  </id_info>
  <brief_title>Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images</brief_title>
  <official_title>Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical, cross-sectional and prospective study to assess the images of the posterior pole of&#xD;
      the retina of patients from the Glaucoma Unit of the IOBA and the Hospital Clínico&#xD;
      Universitario de Valladolid during the period between May and December 2021.&#xD;
&#xD;
      The aim of the project is to provide a sufficient number of images from posterior pole&#xD;
      retinographies in patients with suspected glaucoma or with diagnosis of glaucoma in order to&#xD;
      determine the sensitivity and specificity of an automatic glaucoma screening algorithm&#xD;
      developed by the company Transmural Biotech S.L.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 7, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 7, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity of an automated classification system for retinographies</measure>
    <time_frame>Day 0</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Glaucoma, Suspect</condition>
  <condition>Glaucoma</condition>
  <condition>Ocular Hypertension</condition>
  <arm_group>
    <arm_group_label>Glaucoma</arm_group_label>
    <description>People with diagnosis of Primary Open Angle Glaucoma (POAG)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ocular Hypertension / glaucoma suspect</arm_group_label>
    <description>People with diagnosis of Ocular Hypertension or POAG suspicion</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Fundus Photographs (retinographies)</intervention_name>
    <description>Fundus photographs under mydriasis</description>
    <arm_group_label>Glaucoma</arm_group_label>
    <arm_group_label>Ocular Hypertension / glaucoma suspect</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ocular hypertensive patients or patients with diagnosis of Glaucoma.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary open angle glaucoma or ocular hypertension&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
          -  Visual field examination within the last 12 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ocular or systemic pathologies that may interfere with the quality of the&#xD;
             retinographic image or the results of the visual field&#xD;
&#xD;
          -  Congenital anomalies of the papilla that seriously alter its structure&#xD;
&#xD;
          -  High ametropia (&gt; 10 diopters)&#xD;
&#xD;
          -  Pharmacological Mydriasis contraindication.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jose Carlos Pastor, MD, PhD</last_name>
    <phone>983184734</phone>
    <email>pastor@ioba.med.uva.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Florencia Cellini, MD</last_name>
    <email>florenciacellini87@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IOBA - Universidad de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Carlos Pastor Jimeno, MD PhD</last_name>
      <phone>983184734</phone>
      <email>pastor@ioba.med.uva.es</email>
    </contact>
    <contact_backup>
      <last_name>Florencia Cellini, MD</last_name>
      <email>florenciacellini87@ioba.med.uva.es</email>
    </contact_backup>
    <investigator>
      <last_name>Ramon Juberias Sanchez, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carolina Ossa Calderon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Carlos Pastor Jimeno, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florencia Cellini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 12, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Deep Learning</keyword>
  <keyword>Diagnoses Disease</keyword>
  <keyword>Glaucoma</keyword>
  <keyword>retinographies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Ocular Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

